Quince therapeutics to participate at upcoming investor conferences

South san francisco, calif.--(business wire)---- $qncx #biotech--quince therapeutics, inc. (nasdaq: qncx), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced that management will present at three upcoming investor conferences: 2024 maxim healthcare virtual summit – quince's chief executive officer and chief medical officer dirk thye, m.d., will participate in a fireside chat on thursday, october 17, 2024 beginning at 3.
QNCX Ratings Summary
QNCX Quant Ranking